Since being launched on the international market, Heberprot-P has been registered in more than 20 countries and used to treat some 250,000 people worldwide
A delegation of Cuban health professionals arrived to Slovakia May 24, where they will offer assistance in the application of Heberprot-P, a unique medication developed by the island’s Genetic Engineering and Biotechnology Center (CIGB) to treat diabetic foot ulcers, according to a report published on the Cuban Foreign Ministry website.
Cuba's ability to promote sustainable development has been recognized by the UN's Economic Commission for Latin America and the Caribbean, ECLAC
PORT OF SPAIN.– Cuba's ability to promote sustainable development was recently recognized by the UN's Economic Commission for Latin America and the Caribbean, ECLAC.
Diane Quarless, director of the organization, commented that Cuba is in the vanguard of economic thought and development efforts in the region.